Why it Matters
Medicaid fraud prevention is central to RELX’s lobbying strategy: the company reported a $120,000 quarterly payment to Health Policy Source Inc., continuing a decade-long relationship. That spend comes as Congress advances multiple measures aimed at reducing improper payments and strengthening program integrity.
By the Numbers
RELX Inc. has spent significant resources on lobbying. According to disclosure data, the company has spent $45.82 million on internal lobbying since 2003, with an additional $14.37 million paid to external firms over multiple relationships. The current lobby team includes:
- Keith A. Snider — healthcare veteran
- Daniel Tyler Boston — two decades of healthcare lobbying
- Cynthia Rose Oliver — active since 2024
- Gayle Ley Gerdes — former congressional staffer
Broader Context
Congress has recently increased attention to fraud prevention across federal health programs. The House Budget Committee and the House Energy and Commerce Committee held hearings and markups addressing Medicaid waste and fraud. Members cite large improper payment estimates; for example, Rep. Andrew Clyde referenced roughly $50.3 billion in improper Medicaid payments in 2023.
The Agenda
RELX is lobbying on Medicaid program integrity and fraud prevention measures, including provisions in H.R. 1 related to fraud, waste, and abuse. The company is pitching its data analytics capabilities to support identity verification and provider screening reforms, aligning its commercial offerings with congressional priorities on program integrity.
Competitive Landscape
Several technology and services firms compete in this space, including:
- Socure Inc. — digital identity verification
- ID.me Inc. — government fraud protection lobbying
- SAS Institute Inc. — data analytics
- MAXIMUS Inc. — eligibility verification
Between the Lines
Legislation moving through Congress would expand the use of predictive algorithms and identity checks for oversight. Examples include the Medicare Transaction Fraud Prevention Act and the Medicare and Medicaid Fraud Prevention Act. There is notable bipartisan interest in identity verification solutions and AI-driven predictive modeling; for example, Sen. Maggie Hassan has proposed broader use of predictive tools for fraud detection.
For authoritative background on improper payments and federal program integrity, see the Centers for Medicare & Medicaid Services (CMS) and the Government Accountability Office (GAO).
The Bottom Line
RELX’s continued investment in lobbying on Medicaid fraud prevention aligns the company with congressional priorities and creates business opportunities for its data analytics products. However, increased competition from identity verification and analytics firms means the lobbying
files.
Spot something wrong? Report an issue with this article